Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Composition for treating inflammatory bowel disease

A technology for formulating prescriptions for inflammatory bowel disease, applied in anti-inflammatory agents, drug combinations, pharmaceutical formulas, etc., can solve problems such as large side effects and unsatisfactory effects, achieve good therapeutic effects, prolong human life, and enhance blood supply Effect

Inactive Publication Date: 2016-03-02
何松庆
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The above-mentioned treatment measures are unsatisfactory and have large side effects. Therefore, it is an urgent task for the medical community to study the etiology of inflammatory bowel disease, find the cause of the disease, and take corresponding treatment measures.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0026] 1. Production of Ganoderma lucidum 0.5g, glutamine 1.2g, threonine 0.5g, serine 0.6g, cysteine ​​0.06g, vitamin C 50mg, vitamin E 4mg, vitamin A 0.1mg, β-carotene 0.6mg As a chewable tablet, 2 to 4 times a day.

[0027] 2. Ganoderma lucidum 0.25g, glutamine 0.6g, threonine 0.25g, serine 0.3g, cysteine ​​0.03g, vitamin C 25mg, vitamin E 2mg, vitamin A 0.05mg, β-carotene 0.3mg As a chewable tablet, 2 to 4 times a day.

[0028] 3. Ganoderma lucidum 0.5g, glutamine 1.2g, threonine 0.5g, serine 0.6g, cysteine ​​0.06g, vitamin C 50mg, vitamin E 4mg, vitamin A 0.1mg, β-carotene 0.6mg Injection, 2 to 4 times a day.

[0029] 4. Ganoderma lucidum 0.25g, glutamine 0.6g, threonine 0.25g, serine 0.3g, cysteine ​​0.03g, vitamin C 25mg, vitamin E 2mg, vitamin A 0.05mg, β-carotene 0.3mg Injection, 2 to 4 times a day.

[0030] 5. Ganoderma lucidum 5 grams, glutamine 1.2 grams, threonine 0.5 grams, serine 0.6 grams, cysteine ​​0.06 grams, vitamin C 50 mg, vitamin E 4 mg, vitamin A 0....

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a composition for treating an inflammatory bowel disease and belongs to the field of medicines. The composition comprises ganoderma lucidum, glutamine, threonine, serine, cysteine, vitamins C, E and A and beta-carotene. The ganoderma lucidum has the effects of enhancing blood supply and oxygen supply for a human body. The glutamine is main energy source of the intestinal mucosa. The threonine, the serine and the cysteine are the main constituent parts of mucoprotein. The vitamins C, E and A and the beta-carotene have the effects of inhibiting the oxygen free radical activity, removing oxygen free radicals and protecting human body cells. The composition provides nutrients, oxygen and raw materials for development, update and repair of goblet cells and composition of an intestinal tract surface mucous layer barrier by goblet cell secretory mucoprotein. The composition has the obvious effects of eliminating inflammation, repairing intestinal tissues and establishing the normal intestinal tract surface mucous layer barrier of the human body and is an effective formula for treatment of the inflammatory bowel disease.

Description

technical field [0001] The invention relates to a combination formula of Chinese medicinal materials, amino acids and vitamins for treating inflammatory bowel disease, and belongs to the field of medicines. Background technique [0002] Inflammatory bowel disease (inflammatory bowel disease, IBD) is a disease whose etiology and pathogenesis have not yet been fully clarified. Because the cause of the disease and the pathogenesis have not been fully elucidated, people cannot fundamentally prevent or delay the progress of the disease. [0003] Medical immunology believes that the immune system has abnormal recognition and tolerance to antigens, that is, it produces an immune response to the abnormal recognition of normal intestinal microorganisms, causing the disease. Histology and embryology believe that the high permeability of the intestinal mucosa leads to a large number of intestinal antigens entering the intestinal wall tissue, triggering a long-term response of the immu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/074A61P1/00A61P29/00A61K31/198A61K31/375A61K31/355A61K31/07A61K31/015
CPCA61K9/0056A61K31/015A61K31/07A61K31/198A61K31/355A61K31/375A61K36/074A61K2300/00
Inventor 何松庆
Owner 何松庆
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com